Condition
DTC - Differentiated Thyroid Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 DTC - Differentiated Thyroid Cancer clinical trials that are recruiting, at sites in 2 countries (most in China (1), Japan (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Phase I testing of Af-001 (At-211) for differentiated thyroid cancer
This trial will test Af-001, an experimental At-211 alpha-particle radiopharmaceutical given intravenously, in adults with unresectable, recurrent, or metastatic differentiated thyroid cancer after total thyroidectomy.
-
Using a hormone injection to improve treatment for thyroid cancer
This study is testing whether hormone injections can help improve treatment outcomes for patients with recurring or spreading thyroid cancer compared to stopping their thyroid hormone for a few weeks.
Related topics
Quick answers
How many DTC - Differentiated Thyroid Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.